Side-effect tracking
What the labels say about each GLP-1 side effect, when it tends to show up, and how to log it against every dose.
Nausea on GLP-1s: what to track, when it tends to show up, and how to log it
GLP-1 nausea is the most-listed side effect on the Wegovy, Ozempic, Mounjaro and Zepbound labels. What to log, when it peaks, and how to track it in Peppy.
Read more →Constipation on GLP-1s: what to track, when it tends to show up, and how to log it
GLP-1 constipation is listed on the Wegovy (24%), Zepbound (11–17%) and Saxenda (19%) labels. What to log day to day, red flags, and how to track it in Peppy.
Read more →Sulfur burps on GLP-1s: what to track, when they tend to show up, and how to log them
Sulfur burps (eructation on the labels) are listed for Wegovy (7%), Zepbound (4–5%) and Saxenda (4.5%). When they show up, what to log, and how to track them in Peppy.
Read more →Food noise on GLP-1s: what to track, when it changes, and how to log it
Food noise is the constant background thinking about food that many people say GLP-1s quiet. It is not on any label. How to score it 1–5 and track it in Peppy.
Read more →Heartburn on GLP-1s: what to track, when it tends to show up, and how to log it
GLP-1 heartburn shows on the labels as GERD (Wegovy 5%, Zepbound 4–5%) and dyspepsia (up to 10%). When it hits, what to log, and how to track it in Peppy.
Read more →Diarrhea on GLP-1s: what to track, when it tends to show up, and how to log it
GLP-1 diarrhea is the second most-listed reaction: Wegovy 30%, Zepbound 19–23%, Saxenda 21%, Mounjaro 12–17%. What to log, dehydration red flags, and tracking in Peppy.
Read more →Fatigue on GLP-1s and peptides: what to track, when it tends to show up, and how to log it
GLP-1 fatigue is on the Wegovy (11%), Saxenda (7.5%) and Zepbound (5–7%) labels. When it tends to hit, what to log next to energy and sleep, and how to track it in Peppy.
Read more →Headache on GLP-1s and peptides: what to track, when it tends to show up, and how to log it
GLP-1 headache is on the Wegovy (14%) and Saxenda (13.6%) labels and is commonly reported with GH-secretagogue peptides. What to log and how to track it in Peppy.
Read more →Injection site reactions on GLP-1s and peptides: what to track, where, and how to log them
Injection site reactions range from 0.2% (Ozempic) to 6–8% (Zepbound) and 13.9% (Saxenda) on the labels. What to log per site and how to track it with Peppy's body map.
Read more →Bruising at the injection site: what to track, which sites bruise, and how to log it
Bruising after a GLP-1 or peptide shot is listed as an injection site reaction on the Zepbound and Egrifta labels. What to log per site and how to track it in Peppy.
Read more →Suppressed appetite on GLP-1s: what to track, when it tends to show up, and how to log it
GLP-1 appetite suppression is the intended effect and, on the Mounjaro label, a listed side effect (5–11%). What to log so you can tell useful from too much, and how to track it in Peppy.
Read more →Insomnia on peptides and GLP-1s: what to track, when it tends to show up, and how to log it
Insomnia is listed on the Saxenda label (2.4% vs 1.7%) and reported by many people on growth-hormone peptides. What to log against shot time and how to track it in Peppy.
Read more →Vomiting on GLP-1s: what the labels say, when it tends to show up, and how to track it
GLP-1 vomiting is on every label: Wegovy 24%, Zepbound 8–13%, Saxenda 15.7%, Ozempic 5–9.2%. When it hits, what to log, and how to track it in Peppy.
Read more →Belching on GLP-1s: what the labels call it, when it shows up, and how to log it
GLP-1 belching is listed on the labels as eructation: Wegovy 7%, Zepbound 4–5%, Saxenda 4.5%, Mounjaro about 3%. When it starts, what to log, and how to track it in Peppy.
Read more →Indigestion on GLP-1s: what the labels call it, when it shows up, and how to track it
GLP-1 indigestion is listed on the labels as dyspepsia: Wegovy 9%, Zepbound 9–10%, Saxenda 9.6%, Mounjaro 5–8%, Ozempic 2.7–3.5%. When it hits, what to log, and how to track it in Peppy.
Read more →Stomach pain on GLP-1s: what is expected, what the labels warn about, and how to track it
GLP-1 stomach pain is listed on every label as abdominal pain: Wegovy 20%, Zepbound 9–10%, Ozempic 5.7–7.3%, Mounjaro 5–6%, Saxenda 5.4%. The pancreatitis red flag, what to log, and how to track it in Peppy.
Read more →Dehydration on GLP-1s: why the labels warn about it, what to watch, and how to log it
GLP-1 dehydration is a label warning, not a percentage: vomiting and diarrhea leading to kidney injury. Signs, what to log, and how to track it in Peppy.
Read more →Low blood sugar on GLP-1s: what the labels say, who it mostly affects, and how to log it
GLP-1 low blood sugar is rare alone (Ozempic 1.6–3.8%) but up to 29.8% with insulin; Wegovy 6% in T2D. What to log and how to track it in Peppy.
Read more →Dizziness on GLP-1s: what the labels list, what usually sits behind it, and how to log it
GLP-1 dizziness is on the labels: Wegovy 8% vs 4%, Zepbound 4–5%, Saxenda 6.9%. Often dehydration or under-eating. What to log and how to track in Peppy.
Read more →Increased hunger: late-week hunger on GLP-1s, the hunger that comes with GH peptides, and how to log both
Increased hunger: appetite returning late in a GLP-1 week or after a missed dose, and the hunger many report on ipamorelin, GHRP-6 or MK-677. Log in Peppy.
Read more →Migraine on GLP-1s: what the labels actually list, likely triggers, and how to log it
GLP-1 migraine is on no label; headache is (Wegovy 14% vs 10% placebo). Why fluids and skipped meals matter, what to log, and how Peppy tracks it.
Read more →Mood swings on GLP-1s and peptides: what the labels say, what to log, and when to call
GLP-1 mood swings: the labels list little, and the suicidal ideation warning was removed in 2026. What to log in Peppy and when to call your prescriber.
Read more →Metallic taste on GLP-1s: what the labels call it, when it shows up, and how to log it
GLP-1 metallic taste is dysgeusia on the labels: Wegovy 1.7%, Zepbound 0.4%, Mounjaro 0.1%. What to log, when to call, and how to track it in Peppy.
Read more →Hair loss on GLP-1s: what the labels say, when it tends to show up, and how to log it
GLP-1 hair loss is on the labels: Wegovy 3% (6% at 7.2 mg), Zepbound 4–5%, both tied to weight reduction. What to log, when to call, how Peppy tracks it.
Read more →Water retention on growth hormone peptides: what to track, when it shows up, and how to log it
Peptide water retention (puffy hands, tight rings) is common with GH secretagogues; Egrifta lists peripheral edema at 6% vs 2%. How to log it in Peppy.
Read more →Joint pain on peptides: what to track, when it shows up, and how to log it
Peptide joint pain is reported with GH secretagogues; Egrifta's label lists arthralgia at 13% vs 11%, tied to fluid retention. How to log it in Peppy.
Read more →Numbness and tingling on peptides: what to track, when it shows up, and how to log it
Peptide numbness and tingling is reported with GH secretagogues; Egrifta's label lists paresthesia at 5% vs 2%. What to log and how to track it in Peppy.
Read more →Flushing on peptides and NAD+: what to track, when it shows up, and how to log it
Peptide flushing, the warm red face and chest, is reported most with NAD+ shots and some GH peptides. No label gives a rate. How to log it in Peppy.
Read more →